| Literature DB >> 32664662 |
Giorgia Perri1,2, Nuno Mendonça2,3,4, Carol Jagger5, Jennifer Walsh1,6, Richard Eastell1,6, John C Mathers1,2, Tom R Hill1,2.
Abstract
Background: Selenium is a trace element essential for health. Severe selenium deficiencies are associated with poor musculoskeletal (MSK) function. However, the effects of moderate deficiency on MSK function, especially in older adults, is unclear.Entities:
Keywords: Newcastle 85+ Study; dietary intake; musculoskeletal function; selenium; very old adults
Mesh:
Substances:
Year: 2020 PMID: 32664662 PMCID: PMC7400825 DOI: 10.3390/nu12072068
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow diagram of participant recruitment and sample size at each stage.
List of fifteen first-level food groups used for dietary assessment and analyses.
| Food Group | |
|---|---|
|
| cereal and cereal products |
|
| milk and milk products |
|
| eggs and egg dishes |
|
| oils and fat spreads |
|
| meat and meat products |
|
| fish and fish dishes |
|
| vegetables |
|
| potatoes |
|
| savoury snacks |
|
| nuts and seeds |
|
| fruits |
|
| sugar, preserves and confectionery |
|
| non-alcoholic beverages |
|
| alcoholic beverages |
|
| miscellaneous |
Characteristics of study participants by selenium intake groups (low < 40 µg/d, moderate 40–59, 40–74 µg/d, good ≥ 60, ≥ 75 µg/d for women and men, respectively) at baseline.
| Characteristic | All Participants | Low Se (< 40 µg/d) | Moderate Se (40–59, 40–74 µg/d) | Optimal Se (≥ 60, ≥ 75 µg/d) |
|
|---|---|---|---|---|---|
|
| n = 791 | n = 417 | n = 261 | n = 113 | |
| Women % (n) | 61.8 (489) | 72.9 (304) | 46.7 (122) | 55.7 (63) | < 0.001 a |
| Men % (n) | 38.1 (302) | 27.1 (113) | 53.5 (139) | 44.2 (50) | |
| Years of education % (n) | 0.838 c | ||||
| 0–9 | 64.1 (501) | 65.4 (270) | 64.1 (164) | 59.8 (67) | |
| 10–11 | 23.4 (183) | 22.3 (92) | 24.2 (62) | 25.9 (29) | |
| ≥ 12 | 12.4 (97) | 12.3 (51) | 11.7 (30) | 14.3 (16) | |
| Occupational class % (n) | 0.427 c | ||||
| Managerial and Professional | 26.2 (270) | 33.3 (139) | 31.8 (83) | 32.7 (37) | |
| Intermediate | 11.0 (113) | 13.9 (58) | 11.5 (30) | 18.6 (21) | |
| Routine and Manual | 40.3 (415) | 47.2 (197) | 52.1 (136) | 46.0 (52) | |
| Living in Institution | 0.149 c | ||||
| Yes | 8.7 (69) | 7.4 (31) | 8.8 (23) | 13.3 (15) | |
| No | 91.3 (722) | 92.6 (386) | 91.2 (238) | 86.7 (98) | |
|
| |||||
| Diet change in past year % (n) | 0.502 c | ||||
| Yes | 6.9 (53) | 5.9 (24) | 8.0 (20) | 8.1 (9) | |
| No | 93.1 (718) | 94.1 (385) | 92.0 (231) | 91.9 (102) | |
| Selenium μg/d (Median, IQR) | 39.5, 29.7 | 27.3, 13.9 | 51.4, 12.6 | 87.5, 31.2 | < 0.001 a |
| Total energy kCal (M, SD) | 1678.6, 507.6 | 1492.9, 455.0 | 1841.5, 463.2 | 1987.9, 513.9 | < 0.001 a |
| Carbohydrate | 201.5, 63.2 | 181.9, 58.3 | 218.6, 60.9 | 228.6, 63.4 | < 0.001 a |
| Fat | 69.5, 26.6 | 61.9, 24.0 | 74.7, 25.4 | 83.4, 29.3 | < 0.001 a |
| Protein | 64.9, 22.6 | 53.2, 15.9 | 72.1, 20.6 | 84.4, 26.5 | < 0.001 a |
| Misreporting food intake b % (n) | < 0.001 c | ||||
| Yes | 17.0 (124) | 23.5 (89) | 8.1 (20) | 14.3 (15) | |
| No | 83.0 (606) | 76.5 (290) | 91.9 (226) | 85.7 (90) | |
|
| |||||
| Smoking % (n) | 0.033 c | ||||
| Non-Smoker | 94.3 (745) | 94.5 (393) | 96.2 (251) | 89.4 (101) | |
| Current Smoker | 5.7 (45) | 5.5 (23) | 3.8 (10) | 10.6 (12) | |
| Current alcohol intake % (n) | 0.712 c | ||||
| Yes | 70.9 (380) | 70.4 (197) | 73.0 (127) | 68.3 (56) | |
| No | 29.1 (156) | 29.6 (83) | 27.0 (47) | 31.7 (26) | |
| Physical activity (PA) % (n) | 0.398 c | ||||
| Low (score 0–1) | 22.1 (176) | 24.0 (100) | 19.5 (51) | 22.1 (25) | |
| Moderate (score 2–6) | 40.7 (343) | 44.7 (186) | 42.7 (111) | 40.7 (46) | |
| High (score 7–18) | 37.2 (270) | 31.3 (130) | 37.7 (98) | 37.2 (42) | |
| Selenium Supplement Use | 0.860 c | ||||
| Yes | 3.2 (25) | 3.4 (14) | 2.7 (7) | 3.5 (4) | |
| No | 96.8 (766) | 96.6 (403) | 97.3 (254) | 96.5 (109) | |
|
| |||||
| Self-rated health | 0.270 c | ||||
| Excellent/Very Good | 32.0 (330) | 37.6 (157) | 44.1 (115) | 40.7 (46) | |
| Good | 30.1 (310) | 35.7 (149) | 35.2 (92) | 40.7 (46) | |
| Fair/Poor | 17.9 (184) | 24.2 (101) | 19.2 (50) | 17.7 (20) | |
| Disability Score % (n) n = 785 | 0.036c | ||||
| No Disability | 20.5 (161) | 16.7 (69) | 23.8 (62) | 27.0 (30) | |
| Low (score 1–6) | 52.1 (409) | 54.7 (226) | 51.0 (133) | 45.0 (50) | |
| Moderate (score 7–12) | 18.6 (146) | 17.7 (73) | 19.5 (51) | 19.8 (22) | |
| High (score 13–17) | 8.8 (69) | 10.9 (45) | 5.7 (15) | 8.1 (9) | |
| GDS score (M, SD) | 3.3, 2.4 | 3.3, 2.3 | 3.3, 2.3 | 3.4, 2.6 | 0.713 a |
| Cognitive Impairment (M, SD) | 0.948 a | ||||
| Normal (26–30 SMMSE score) | 27.3, 2.7 | 27.3, 2.8 | 27.3, 2.6 | 27.4, 2.6 | |
| Free T4 in pmol/L (M, SD) | 15.6, 2.6 | 15.7, 2.7 | 15.5, 2.4 | 15.8, 2.9 | 0.778 a |
| Free T3 in pmol/L (M, SD) | 4.6, 0.5 | 4.5, 0.5 | 4.6, 0.6 | 4.6, 0.5 | 0.002 a |
| Phase 1 Arthritis in hands % (n) | 0.202 c | ||||
| Yes | 7.1 (55) | 8.6 (35) | 5.9 (15) | 4.5 (5) | |
| No | 92.9 (719) | 91.4 (371) | 94.1 (241) | 95.5 (107) | |
| Phase 1 Walking Aids % (n) | 0.046 c | ||||
| Yes | 17.8 (131) | 20.9 (81) | 13.2 (32) | 17.1 (18) | |
| No | 82.2 (604) | 79.1 (306) | 86.8 (211) | 82.9 (87) | |
| HGS Phase 1 (M, SD) | 18.7, 7.7 | 16.8, 7.2 | 20.8, 7.5 | 20.0, 7.8 | < 0.001 b |
| TUG Phase 1 (M, SD) | 17.3, 13.1 | 18.3, 13.5 | 16.7, 14.2 | 15.1, 6.8 | 0.009 a |
|
| |||||
| BMI (M, SD) | 24.5, 4.4 | 24.6, 4.7 | 24.6, 4.0 | 24.0, 4.0 | 0.636 a |
a: Kruskal–Wallis test for ordered and non-normally distributed continuous variables. b: One-way ANOVA for normally distributed data. c: χ2 test was used for all other categorical variables. TUG: timed up and go. HGS: hand grip strength.
Untransformed hand grip strength and timed up-and-go scores by selenium intake groups at baseline and follow-up.
| Physical Performance | All Participants | Low Se | Moderate Se | Optimal Se |
|
|---|---|---|---|---|---|
|
| |||||
| Baseline (n) | 813 | 401 | 254 | 112 | |
| kg (M, SD) | 17.5, 7.7 | 16.0, 7.1 | 19.8, 7.8 | 18.8, 8.2 | < 0.001 a |
| Hand arthritis, % (n) yes | 0.1 (55) | 63.6 (35) | 27.3 (15) | 0.1 (5) | 0.202 b |
| Follow-up at 1.5 years (n) | 605 | 306 | 198 | 90 | |
| kg (M, SD) | 16.9, 7.8 | 15.3, 6.9 | 19.3, 8.3 | 17.7, 8.2 | < 0.001 a |
| Follow-up at 3 years (n) | 452 | 226 | 148 | 71 | |
| kg (M, SD) | 16.4, 7.3 | 15.0, 6.3 | 18.1, 7.9 | 17.4, 7.9 | < 0.001 a |
| Follow-up at 5 years (n) | 294 | 140 | 97 | 54 | |
| kg (M, SD) | 14.9, 7.0 | 13.7, 6.5 | 15.7, 7.1 | 16.7, 7.6 | 0.008 a |
|
| |||||
| Baseline (n) | 747 | 387 | 243 | 105 | |
| s (M, SD) | 18.7, 14.7 | 19.7, 15.4 | 17.5, 14.5 | 17.4, 12.3 | 0.009 c |
| Use of walking aids, % (n) yes | 17.8 (131) | 61.8 (81) | 24.4 (32) | 13.7 (18) | 0.046 b |
| Follow-up at 1.5 years (n) | 547 | 277 | 184 | 80 | |
| s (M, SD) | 21.4, 17.1 | 22.2, 16.1 | 20.4, 15.1 | 20.7, 23.6 | 0.095 c |
| Use of walking aids, % (n) yes | 16.6 (90) | 56.7 (51) | 27.8 (25) | 15.6 (14) | 0.407 b |
| Follow-up at 3 years (n) | 402 | 199 | 134 | 63 | 0.098 c |
| s (M, SD) | 21.5, 18.8 | 21.5, 14.2 | 21.3, 21.8 | 19.4, 14.5 | |
| Use of walking aids, % (n) yes | 17.7 (70) | 57.1 (40) | 30.3 (21) | 12.9 (9) | 0.421 b |
| Follow-up at 5 years (n) | 274 | 134 | 86 | 49 | |
| s (M, SD) | 20.8, 12.2 | 21.9, 13.8 | 19.1, 9.7 | 20.1, 10.2 | 0.529 c |
| Use of walking aids, % (n) yes | 26.1 (71) | 49.3 (35) | 29.6 (21) | 21.1 (15) | 0.733 b |
a: Student t-test for normally distributed continuous variables. b: χ2 test for categorical variables. c: Kruskal–Wallis test for non-normally distributed continuous data (untransformed).
Figure 2Mean hand grip strength (HGS) (A) and timed-up-and-go (TUG) (B) values across 5 years divided by selenium intakes: below lower reference nutrient intake (LRNI) (below 40 µg/d), LRNI-reference nutrient intake (RNI) (between 40 and 59 and 40 and 74 µg/d for women and men, respectively) and RNI and above (≥ 60 and ≥ 75 µg/d for women and men, respectively). Time intervals between each measurement were not consistent: 0, 1.5, 3 and 5 years.
Hand grip strength (kg) and timed-up-and-go (log10-s) trajectory estimates in low, moderate and optimal selenium over 5 years separated by sex.
| Outcome | Variable | Model 3 | |
|---|---|---|---|
| β (SE) |
| ||
| HGS (kg) | Intercept | 25.36 (33.11) | 0.444 |
| ALL INDIVIDUALS | Se intake group | ||
| Low Se | −0.69 (0.65) | 0.292 | |
| Moderate Se | 0.14 (0.64) | 0.829 | |
| Decline | |||
| Time | −1.31 (0.17) | < 0.001 | |
| Slopes (rate of decline) | |||
| Se intake × Time | |||
| Low Se × Time | 0.09 (0.20) | 0.650 | |
| Moderate Se | −0.18 (0.21) | 0.387 | |
| HGS (kg) | Intercept | 125.81 (59.65) | 0.036 |
| MEN | Se intake group | ||
| Low Se | 1.19 (1.19) | 0.317 | |
| Moderate Se | 0.94 (1.07) | 0.384 | |
| Decline | |||
| Time | −1.69 (0.31) | < 0.001 | |
| Slopes (rate of decline) | |||
| Se intake × Time | |||
| Low Se × Time | −0.25 (0.39) | 0.513 | |
| Moderate Se | −0.16 (0.37) | 0.669 | |
| HGS (kg) | Intercept | −23.82 (34.80) | 0.045 |
| WOMEN | Se intake group | ||
| Low Se | −0.91 (0.69) | 0.184 | |
| Moderate Se | −0.08 (0.73) | 0.915 | |
| Decline | |||
| Time | −1.05 (0.18) | < 0.001 | |
| Slopes (rate of decline) | |||
| Se intake × Time | |||
| Low Se × Time | 0.10 (0.21) | 0.626 | |
| Moderate Se | −0.05 (0.23) | 0.826 | |
| TUG (log10-s) | Intercept | 1.65 (1.08) | 0.126 |
| ALL INDIVIDUALS | Se intake group | ||
| Low Se | −0.002 (0.024) | 0.364 | |
| Moderate Se | −0.009 (0.024) | 0.722 | |
| Decline | |||
| Time | 0.051 (0.010) | < 0.001 | |
| Slopes (rate of decline) | |||
| Se intake × Time | |||
| Low Se × Time | 0.020 (0.012) | 0.091 | |
| Moderate Se | 0.013 (0.013) | 0.301 | |
| TUG (log10-s) | Intercept | −2.949 (3.239) | 0.365 |
| MEN | Se intake group | ||
| Low Se | −0.016 (0.045) | 0.730 | |
| Moderate Se | 0.031(0.041) | 0.457 | |
| Decline | |||
| Time | 0.054 (0.013) | < 0.001 | |
| Slopes (rate of decline) | |||
| Se intake × Time | |||
| Low Se × Time | 0.002 (0.016) | 0.917 | |
| Moderate Se | −0.010 (0.015) | 0.507 | |
| TUG (log10-s) | Intercept | 0.629 (2.305) | 0.785 |
| WOMEN | Se intake group | ||
| Low Se | −0.023 (0.037) | 0.541 | |
| Moderate Se | −0.029 (0.039) | 0.462 | |
| Decline | |||
| Time | 0.042 (0.010) | < 0.001 | |
| Slopes (rate of decline) | |||
| Se intake × Time | |||
| Low Se × Time | 0.006 (0.011) | 0.577 | |
| Moderate Se | 0.003 (0.012) | 0.801 | |
SE, standard error, selenium intakes were divided by below LRNI (< 40 µg/d) and moderate intakes (41–59, 41–74 µg/d in females and males, respectively). Adequate selenium intakes were used a reference. Model 3 is adjusted for presence of hand arthritis or use of walking aids, age at baseline, sex, National Statistics Socio-Economic Classification (NS-SEC), self-rated health, energy intake, protein intake, medication use, body mass index (BMI), fat-free mass physical activity, cognitive impairment, disability score, misreporters, change in diet. Estimated β coefficients (SE) using HGS and TUG longitudinal data.
Figure 3Linear slopes for musculoskeletal measures over time with the presence of hand arthritis (hand grip strength, HGS, A) or the use of walking aids (timed-up-and-go, TUG, B) as predictors in addition to age at baseline, sex, National Statistics Socio-Economic Classification (NS-SEC), self-rated health, energy intake, protein intake, medication use, body mass index (BMI), fat-free mass, physical activity, cognitive impairment, disability score, misreporters and change in diet. Time intervals between each measurement were not consistent: 0, 1.5, 3 and 5 years.